KERRI BOEMIO: Open Payments
NPI 1427715267 · ISLAND HEIGHTS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,442 in 319 payments from 43 companies in 2025. Trend: 2023 $4,618 · 2024 $5,281 · 2025 $5,442
Food & beverage: $5,361Education: $81
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 37 | $1,071 |
| ABBVIE INC. | 35 | $445 |
| Regeneron Healthcare Solutions, Inc. | 14 | $321 |
| Corcept Therapeutics | 22 | $311 |
| Kowa Pharmaceuticals America, Inc. | 19 | $264 |
| PFIZER INC. | 16 | $238 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $216 |
| Amgen Inc. | 12 | $184 |
| GlaxoSmithKline, LLC. | 11 | $163 |
| Lilly USA, LLC | 10 | $150 |
Products named: FASENRA, DUPIXENT, Korlym, ZORYVE, VRAYLAR, XIFAXAN, UBRELVY, NEXLETOL.
Industry payments across NJ — which companies pay providers there.
